Researchers have found that specific small molecules in blood plasma may be useful in determining whether someone has sustained a mild traumatic brain injury (mTBI), commonly known as a concussion.

Often people think performing in front of others will make them mess up, but a new study found the opposite: being watched makes people do better.

Cancer immune cell therapy has made headlines with astounding successes like saving former US President Jimmy Carter from brain cancer. But immunotherapy has also had many tragic flops. Researchers working to optimize the innovative treatment have impl…

A new recycling process turns discarded hard disk drive magnets into new magnet material in a few steps, and tackles both the economic and environmental issues typically associated with mining e-waste for valuable materials.

Researchers have shown that adenovirus binds to a specific type of carbohydrate that is overexpressed on certain types of cancer cells. The discovery opens up new opportunities for the development of virus-based cancer therapy.

Epidemiologists and geologists have found associations between esophageal cancer and soils where lead is abundant, lung cancer and terrains with increased copper content, brain tumor with areas rich in arsenic, and bladder cancer with high cadmium leve…

New research has shown that carefully structured light and matching arrangements of metal nanostructures can be combined to alter the properties of the generated light at the nanometer scale. The teams have shown that the efficiency of nonlinear optica…

The vampire bat prefers to feed on domestic animals such as cows and pigs. When it does so, there is a risk of transmission of pathogens. Now, a new study describes a new DNA method to efficiently screen many vampire bat blood meal and fecal samples wi…

Little is still known about the exact causes of irritable bowel syndrome. An international team has provided initial clues about the organic triggers of the disease, which affects an estimated one out of six people.

New research indicates that belimumab, a monoclonal antibody therapy that targets a component of the immune system, provides considerable benefits to patients with systemic lupus erythematosus (SLE), a predominately female, chronic inflammatory disease…